FDA Drug Recalls

Recalls / Class II

Class IID-628-2013

Product

Sodium Chloride Injection, USP, a) Product code 2B1301- 50 mL in Viaflex Container Quad Pack (NDC 0338-0049-11); b) 2B1302- 100mL in Viaflex Quad Pack (NDC 0338-0049-18); c) 2B1306- 50 mL in Viaflex Single Pack (NDC 0338-0049-41; d) 2B1307- 100mL in Viaflex Single Pack (NDC 0338-0049-48); e) 2B1308- 50 ML in Viaflex Multi Pack (NDC 0338-0049-31); f) 2B1309- 100mL in Viaflex Multi Pack (NDC 0338-0049-38), Rx Only, Baxter, Deerfield, IL 60015

Brand name
Sodium Chloride
Generic name
Sodium Chloride
Active ingredient
Sodium Chloride
Route
Intravenous
NDCs
0338-0043, 0338-0049
FDA application
NDA018016
Affected lot / code info
Lot #: a) Product code 2B1301: P279943, P280370, Exp 7/13; b) Product code 2B1302: P280248, P280248A, P280248B, P285346, P285791, Exp 8/13; c) Product code 2B1306: P285601, Exp 5/13; d) Product code 2B1307: P280347, Exp 8/13; e) Product code 2B1308: P280404, P280404A, P285635, P285858, Exp 11/13; e) Product code 2B1309: P280149, Exp 8/13

Why it was recalled

Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.

Recalling firm

Firm
Baxter Healthcare Corp.
Manufacturer
Baxter Healthcare Corporation
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1 Baxter Pkwy, N/A, Deerfield, Illinois 60015-4625

Distribution

Quantity
1,788,292 units
Distribution pattern
Nationwide & Puerto Rico

Timeline

Recall initiated
2013-05-21
FDA classified
2013-06-28
Posted by FDA
2013-07-10
Terminated
2015-06-18
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-628-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.